Avaxia Biologics Company
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts.
Industry:
Geroscience
Headquarters:
Lexington, Massachusetts, United States
Zip:
11-50
Founded Date:
2005-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Acquisitions Number:
16
Investors Number:
35257137
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Convertible Note
Last Funding Type:
info@avaxiabiologics.com
Register and Claim Ownership